Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by Translational Research in Oncology
Boehringer Ingelheim
Information provided by (Responsible Party):
Translational Research in Oncology Identifier:
First received: April 9, 2014
Last updated: May 19, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)